万东医疗前三季度净利亏损2720.98万元，同比由盈转亏

Core Viewpoint - WanDong Medical (600055) reported a revenue of 1.189 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 8.73%, while the net profit attributable to shareholders was a loss of 27.21 million yuan, a decline of 123.51% year-on-year [1] Financial Performance - The company's revenue for the first three quarters reached 1.189 billion yuan, marking an increase of 8.73% compared to the previous year [1] - The net profit attributable to shareholders was -27.21 million yuan, indicating a significant decline of 123.51% year-on-year [1] Reasons for Performance Changes - The decline in net profit is attributed to changes in sales strategies and the gradual delivery of centralized procurement projects, which led to a decrease in the company's gross profit margin [1] - The company has also been increasing its investment in research and development, contributing to the overall performance changes [1]